Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmelo Nucera

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Frontiers in Endocrinology|August 6, 2019
Clonal Reconstruction of Thyroid Cancer: An Essential Strategy for Preventing Resistance to Ultra-Precision TherapyElizabeth R McGonagle, Carmelo Nucera
Cancer Research|March 31, 2011
BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progressionCarmelo Nucera, Jack Lawler, Sareh Parangi
Oncotarget|February 16, 2011
The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?Carmelo Nucera, Jack Lawler, Richard Hodin, et al.
Biochimica Et Biophysica Acta|April 10, 2009
Role of B-Raf(V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E)Carmelo Nucera, Melanie Goldfarb, Richard Hodin, et al.
Cancer Letters|July 21, 2015
Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(V600E)Amjad Husain, Nina Hu, Peter M Sadow, et al.
Frontiers in Endocrinology|December 19, 2013
Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells with BRAF(V600E): New Insights in the Host Tissue Adaptation and Homeostasis of Tumor MicroenvironmentMark Duquette, Peter M Sadow, Jack Lawler, et al.
Frontiers in Endocrinology|November 9, 2020
Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAF<sup>V600E</sup>: New Insights in the Host Tissue Adaptation and Homeostasis of Tumor MicroenvironmentMark Duquette, Peter M Sadow, Jack Lawler, et al.
American Journal of Surgery|July 20, 2010
Surgical implications of B-RafV600E mutation in fine-needle aspiration of thyroid nodulesMichal Mekel, Carmelo Nucera, Richard A Hodin, et al.
Surgery|December 8, 2010
Thyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic thyroid cancerMatthew A Nehs, Sushruta Nagarkatti, Carmelo Nucera, et al.
The Journal of Clinical Endocrinology and Metabolism|July 24, 2021
Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational InsightsAsumi Iesato, Stephanie Li, Giovanni Roti, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Frontiers in Endocrinology|August 6, 2019
Clonal Reconstruction of Thyroid Cancer: An Essential Strategy for Preventing Resistance to Ultra-Precision TherapyElizabeth R McGonagle, Carmelo Nucera
Cancer Research|March 31, 2011
BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progressionCarmelo Nucera, Jack Lawler, Sareh Parangi
Oncotarget|February 16, 2011
The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?Carmelo Nucera, Jack Lawler, Richard Hodin, et al.
Biochimica Et Biophysica Acta|April 10, 2009
Role of B-Raf(V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E)Carmelo Nucera, Melanie Goldfarb, Richard Hodin, et al.
Cancer Letters|July 21, 2015
Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(V600E)Amjad Husain, Nina Hu, Peter M Sadow, et al.
Frontiers in Endocrinology|December 19, 2013
Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells with BRAF(V600E): New Insights in the Host Tissue Adaptation and Homeostasis of Tumor MicroenvironmentMark Duquette, Peter M Sadow, Jack Lawler, et al.
Frontiers in Endocrinology|November 9, 2020
Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAF<sup>V600E</sup>: New Insights in the Host Tissue Adaptation and Homeostasis of Tumor MicroenvironmentMark Duquette, Peter M Sadow, Jack Lawler, et al.
American Journal of Surgery|July 20, 2010
Surgical implications of B-RafV600E mutation in fine-needle aspiration of thyroid nodulesMichal Mekel, Carmelo Nucera, Richard A Hodin, et al.
Surgery|December 8, 2010
Thyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic thyroid cancerMatthew A Nehs, Sushruta Nagarkatti, Carmelo Nucera, et al.
The Journal of Clinical Endocrinology and Metabolism|July 24, 2021
Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational InsightsAsumi Iesato, Stephanie Li, Giovanni Roti, et al.
Pageof 5